Given the above regulation of YAP by RNF43 in ccRCC, we next examined whether combining the two biomarkers better predicted the ccRCC patient prognosis than either biomarker individually or better than current clinical indicators alone, such as TNM stage and SSIGN (Fig. 8a). Here, RNF43 is linked to nonpapillary renal cell carcinoma.